Skip To The Main Content
Andrew Alin
 

Andrew Alin

Partner
 
425 Lexington Avenue
New York, NY 10017 

A trusted adviser for companies, private equity sponsors and financial institutions, Andy Alin represents clients on a variety of their most complex transactions. He has extensive experience advising on mergers, acquisitions, divestitures, joint ventures, carve outs and spinoffs as well as on corporate governance matters. His work on high-profile deals spans several sectors, including technology, life sciences, FinTech and financial institutions and he is consistently recognized by IFLR 1000 in M&A and Private Equity Transactions. 

Read Full Biography...

Work Highlights

Notable experience prior to joining Simpson Thacher includes advising:

  • The Herb Chambers Companies in the pending sale of its auto dealership operations to Asbury Automotive Group, Inc. for approximately $1.34 billion in cash.
  • Penn Mutual in its sale of Janney Montgomery Scott, a leading wealth management, investment banking and asset management firm, to KKR.
  • TechTarget, Inc. in connection with its combination with Informa PLC providing for Informa’s contribution of Informa Tech’s digital business and $350 million in cash in exchange for a 57% stake in the combined company.
  • Akamai Technologies, Inc. in connection with its acquisition of Linode Limited Liability Company, for cash consideration of $900 million
  • Salix Pharmaceuticals, Ltd. in its $15.6 billion acquisition by Valeant Pharmaceuticals International, Inc.
  • A consortium consisting of WL Ross & Co. LLC, The Blackstone Group, The Carlyle Group, Centerbridge Capital Partners, other investors and a management team led by John Kanas in their $900 million acquisition of the banking operations of BankUnited, FSB in an auction by the FDIC, as receiver. This deal was named “Private Equity Deal of the Year” by International Financial Law Review.
  • BankUnited, Inc. in several transactions, including: its $900 million initial public offering, the then-largest U.S. bank IPO in history; its acquisition of the Small Business Finance unit of CertusHoldings; its acquisition of Herald National Bank; and its acquisitions of its municipal finance and commercial leasing platforms from Koch Financial Corporation and Butler Capital Corporation, respectively.
Accolades
  • IFLR 1000 “Notable Practitioner” in M&A and Private Equity
Education
  • University of Pennsylvania Law School, 2004 J.D.
    cum laude
  • University of Pennsylvania, 2001 B.A.
    magna cum laude
Admissions
  • New York 

As a Partner in Simpson Thacher’s Mergers and Acquisitions Practice, Andrew Alin is a trusted adviser to significant companies, private equity sponsors and financial institutions on their most complex transactions. Consistently recognized by IFLR 1000 in M&A and Private Equity Transactions, Andy’s experience spans mergers, acquisitions, divestitures, joint ventures, carve outs and spinoffs across several sectors, including technology, life sciences, FinTech and financial institutions. He also regularly advises on corporate governance matters.  

Notable experience prior to joining Simpson Thacher includes advising:

  • The Herb Chambers Companies in the pending sale of its auto dealership operations to Asbury Automotive Group, Inc. for approximately $1.34 billion in cash
  • Penn Mutual, one of the longest-operating insurers in the U.S., in connection with its agreement to sell Janney Montgomery Scott to KKR
  • TechTarget, Inc. in connection with its combination with Informa PLC providing for Informa’s contribution of Informa Tech’s digital business and $350 million in cash in exchange for a 57% stake in the combined company
  • SDC Capital Partners, a global investment firm specializing in digital infrastructure, in its sale of Fatbeam Holdings to funds managed by Basalt Infrastructure Partners LLC
  • Merchants Fleet, the nation’s fourth largest provider of fleet management services, in its acquisition by Bain Capital and a wholly owned subsidiary of the Abu Dhabi Investment Authority
  • Akamai Technologies, Inc. in connection with its acquisition of Linode Limited Liability Company, for cash consideration of $900 million
  • XL Fleet Corp. in its acquisition of Spruce Power, the largest privately-held owner and operator of residential rooftop solar systems in the U.S., for $58 million in cash and the assumption of approximately $542 million of debt
  • ·one, a special purpose acquisition company, in its $2.1 billion business combination transaction with MarkForged, Inc.
  • Community Bank System, Inc. in several transactions, including: its $98 million acquisition of Steuben Trust Corporation; its acquisition of Kinderhook Bank Corp.; its $352 million acquisition of Merchants Bancshares, Inc.; and its $140 million acquisition of Northeast Retirement Services, Inc.
  • The largest shareholder of LendingClub in connection with its acquisition of Radius Bancorp, the first acquisition of a bank by a marketplace lending platform
  • A consortium consisting of WL Ross & Co. LLC, The Blackstone Group, The Carlyle Group, Centerbridge Capital Partners, other investors and a management team led by John Kanas in their $900 million acquisition of the banking operations of BankUnited, FSB in an auction by the FDIC, as receiver
  • BankUnited, Inc. in several transactions, including: its $900 million initial public offering, the then-largest U.S. bank IPO in history; its acquisition of the Small Business Finance unit of CertusHoldings; its acquisition of Herald National Bank; and its acquisitions of its municipal finance and commercial leasing platforms from Koch Financial Corporation and Butler Capital Corporation, respectively.
  • Seacoast Banking Corporation of Florida in several matters, including: its successful defense against a withhold the vote campaign by CapGen Capital Group and entry into an Observer Rights Agreement with Basswood Capital Management; and its acquisitions of Floridian Financial Group, Inc. and GulfShore Bancshares, Inc.
  • Salix Pharmaceuticals, Ltd. in its $15.6 billion acquisition by Valeant Pharmaceuticals International, Inc.

Andy received his J.D. from University of Pennsylvania Law School in 2004, cum laude, and his B.A. from University of Pennsylvania in 2001, magna cum laude. He is admitted to practice in New York.

News & Events

    Publications